Britecyte is a biotechnology business focused on finding novel solutions In new technology for single-cell analysis.
Britecyte has raised $1.0M in total funding. The most recent round was Grant. The last funding was announced in November 2025.
Britecyte's investors include Maryland Stem Cell Research Fund (MSCRF).
Britecyte is headquartered in Frederick, United States.
Britecyte is a biotechnology business focused on finding novel solutions In new technology for single-cell analysis.
Britecyte is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Britecyte — Funding & Investors." VCBacked, November 4, 2025, https://www.vcbacked.co/company/britecyte. Accessed September 30, 2026.
VCBacked. (2025). Britecyte — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/britecyte
{{cite web |title=Britecyte — Funding & Investors |url=https://www.vcbacked.co/company/britecyte |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated